Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors

Journal of Surgical Oncology

Volumn 114, Issue 5, 2016, Pages 642-648

  Gravante, Gianpiero ^a   Hemingway, David ^a   Stephenson, James Andrew ^a   Sharpe, David ^a   Osman, Ahmed ^a   Haines, Melissa ^a   Pirjamali, Vafa ^a   Sorge, Roberto ^b   Yeung, Justin Ming ^a   Norwood, Michael ^a   Miller, Andrew ^a   Boyle, Kirsten ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

circumferential margins; colorectal cancer; prognostic factors; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT RADIOTHERAPY; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HARTMANN PROCEDURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANPROCTOCOLECTOMY; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; RETROSPECTIVE STUDY; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; CANCER STAGING; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; NEOADJUVANT THERAPY; PATHOLOGY; RECTAL NEOPLASMS; SURGICAL MARGIN; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MARGINS OF EXCISION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84992028296     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24360     Document Type: Article

References (34)

1. Tilney HS, Rasheed S, Northover JM, et al.: The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery. Dis Colon Rectum 2009; 52:1723–1729.
2. Wieder HA, Rosenberg R, Lordick F, et al.: Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 2007; 243:744–751.
3. Taylor FG, Quirke P, Heald RJ, et al.: One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011; 98:872–879.
4. Debove C, Maggiori L, Chau A, et al.: Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: A study in 233 consecutive patients with mid or low rectal cancer. Int J Colorectal Dis 2015; 30:197–203.
5. Homan J, Bokkerink GM, Aarts MJ, et al.: Variation in circumferential resection margin: Reporting and involvement in the South-Netherlands. Eur J Surg Oncol 2015; 41:1485–1492.
6. Salerno G, Daniels IR, Brown G, et al.: Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer. World J Surg 2007; 31:1313–1320.
7. Boyle KM, Petty D, Chalmers AG, et al.: MRI assessment of the bony pelvis may help predict resectability of rectal cancer. Colorectal Dis 2005; 7:232–240.
8. Tilly C, Lefevre JH, Svrcek M, et al.: R1 rectal resection: Look up and don't look down. Ann Surg 2014; 260:794–799; discussion 799–800.
9. Chambers W, Collins G, Warren B, et al.: Benchmarking circumferential resection margin (R1) resection rate for rectal cancer in the neoadjuvant era. Colorectal Dis 2010; 12:909–913.
10. Debove C, Maggiori L, Chau A, et al.: What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients. Colorectal Dis 2015; 17:197–204.
11. Shihab OC, Quirke P, Heald RJ, et al.: Brown G: Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 2010; 97:1431–1436.
12. Pettersson D, Lorinc E, Holm T, et al.: Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg 2015; 102:972–978; discussion 978.
13. Klein M, Fischer A, Rosenberg J, et al.: Extralevatory abdominoperineal excision (ELAPE) does not result in reduced rate of tumor perforation or rate of positive circumferential resection margin: A nationwide database study. Ann Surg 2015; 261:933–938.
14. Simpson GS, Eardley N, McNicol F, et al.: Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection. Int J Colorectal Dis 2014; 29:585–590.
15. Birbeck KF, Macklin CP, Tiffin NJ, et al.: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235:449–457.
16. Wittekind C, Compton CC, Greene FL, et al.: TNM residual tumor classification revisited. Cancer 2002; 94:2511–2516.
17. Nougaret S, Reinhold C, Mikhael HW, et al.: The use of MR imaging in treatment planning for patients with rectal carcinoma: Have you checked the “DISTANCE”. Radiology 2013; 268:330–344.
18. Leonard D, Penninckx F, Laenen A, et al.: Scoring the quality of total mesorectal excision for the prediction of cancer-specific outcome. Colorectal Dis 2015; 17:O115–O122.
19. Quirke P, Steele R, Monson J, et al.: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373:821–828.
20. Wittekind C, Compton C, Quirke P, et al.: A uniform residual tumor (R) classification: Integration of the R classification and the circumferential margin status. Cancer 2009; 115:3483–3488.
21. Tekkis PP, Heriot AG, Smith J, et al.: Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis 2005; 7:369–374.
22. Khan MA, Hakeem AR, Scott N, et al.: Significance of R1 resection margin in colon cancer resections in the modern era. Colorectal Dis 2015; 17:943–953
23. Anderin C, Martling A, Hellborg H, et al.: A population-based study on outcome in relation to the type of resection in low rectal cancer. Dis Colon Rectum 2010; 53:753–760.
24. Shihab OC, Brown G, Daniels IR, et al.: Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum 2010; 53:53–56.
25. Bipat S, Glas AS, Slors FJ, et al.: Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology 2004; 232:773–783.
26. Huh JW, Lim SW, Kim HR, et al.: Effects of postoperative adjuvant radiotherapy on recurrence and survival in stage III rectal cancer. J Gastrointest Surg 2011; 15:963–970.
27. Edge SB, Byrd DR, Compton CC: AJCC (American Joint Committee on Cancer) cancer staging manual, 7th ed. New York: Springer; 2010.
28. Shimomura M, Ikeda S, Takakura Y, et al.: Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer. Surg Today 2011; 41:1370–1379.
29. Park YH, Lee JI, Park JK, et al.: Clinical significance of lymph node ratio in stage III colorectal cancer. J Korean Soc Coloproctol 2011; 27:260–265.
30. Kim YS, Kim JH, Yoon SM, et al.: Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009; 74:796–802.
31. Zhang J, Lv L, Ye Y, et al.: Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J Cancer Res Clin Oncol 2013; 139:1947–1953.
32. Kobayashi H, Mochizuki H, Kato T, et al.: Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: A Japanese multicenter study. Int J Colorectal Dis 2011; 26:891–896.
33. Ceelen W, Van Nieuwenhove Y, Pattyn P: Prognostic value of the lymph node ratio in stage III colorectal cancer: A systematic review. Ann Surg Oncol 2010; 17:2847–2855.
34. Noura S, Ohue M, Kano S, et al.: Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg 2010; 2:70–77.